MN-08

· Guangzhou Magpie Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MN-08, covering 2025-03-19 to 2025-03-19. Get the full timeline:

Most recent: Clinical Trial Update: A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of MN-08 Tablets [Phase 1]